生物医学应用的聚氨聚合物的最新进展
Amol D Gholap1,2, Rushikesh P Said3, Pankaj R Khuspe4
1Department of Pharmaceutics, St. John Institute of Pharmacy and Research, Palghar, Maharashtra 401404, India.
Molecular pharmaceutics
|October 28, 2025
概括
聚氨 (PU) 为生物医学用途提供可调节的特性. 研究正在探索可持续的PU,以克服未来医疗创新的生物降解性和生物相容性等挑战.
科学领域:
- 聚合物科学和生物材料工程 聚合物科学和生物材料工程
背景情况:
- 聚氨 (PU) 是具有可适应性质的高度多功能聚合物,使其适合于众多生物医学应用.
- 聚合和表面修饰技术的进步显著提高了用于专业用途的PU的功能.
研究的目的:
- 审查聚氨的合成,化学和表面修饰.
- 提供商业上可用的PU,专利及其各种生物医学应用的概述.
- 突出PU基生物材料的最新进展,挑战和未来趋势.
主要方法:
- 科学出版物,专利和市场分析的文献综述.
- 聚乙烯材料的合成和表征.
- 对用于生物医学应用的PU特性进行评估.
主要成果:
- 聚烯被用于涂料,植入物,组织工程,药物输送和心血管设备.
- 最近的进展侧重于生物相容性,降解和市场趋势.
- 挑战包括生物降解性,长期生物相容性,机械限制和细菌殖民.
结论:
- 聚氨对生物医学应用具有显著的优势.
- 解决生物降解性和生物相容性方面的挑战对于未来的发展至关重要.
- 可持续和可生物降解的PU配方为下一代医疗创新提供了希望.
相关概念视频
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:27Bioplastics
Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...